Czech urology, 2023 (vol. 27), issue 2

Urologie a elektronizace zdravotnictví

MUDr. Aleš Petřík, Ph.D.

Ces Urol 2023, 27(2):65-66  

Robotic laparoscopic pyeloplasty

Ágnes Juhász, Lukáš Fišer, Milan Čermák, Luboš Hyršl, Jiří Kočárek

Ces Urol 2023, 27(2):67-69  

Juhász A, Fišer L, Čermák M, Hyršl L, Kočátek J. Robotic laparoscopic pyeloplasty. Introduction: Laparoscopic pyeloplasty is one of the most demanding laparoscopic surgical procedure. The reason is the necessity of precise tissue preparation, spatulation of the ureter, resection of the pelvis and suturing of the anastomosis of the pelvis and ureter with rigid laparoscopic instruments. Robotic systems provide us with significant help, their disadvantage is however, that they are not available at all workplaces. New to the market are robotic laparoscopic instruments that are more affordable, combining advantages of conventional laparoscopy and robotics....

The WHO Classification of Urinary and Male Genital Tumours 2022: renal tumours classification

Adriena Bartoš Veselá, Tomáš Pitra, Jiří Kolář, Josef Skopal, Ondřej Fiala, Milan Hora, Ondřej Hes, Kristýna Pivovarčíková

Ces Urol 2023, 27(2):70-77 | DOI: 10.48095/cccu2023008  

Bartoš Veselá A, Pitra T, Kolář J, Skopal J, Fiala O, Hora M, Hes O, Pivovarčíková K. The WHO Classification of Urinary and Male Genital Tumours 2022: renal tumours classification. The 5th edition WHO (World Health Organization) classification of the urogenital tract tumors was published in the middle of last year (so-called blue book). The new WHO classification reflects very dynamic developments in the field of renal neoplasms (caused mainly by the more frequent implementation of molecular genetic testing into the routine diagnosis of kidney tumors), and the new WHO classification shows changes especially in the chapter on renal tumors. The new kidney...

5th edition of the 2022 WHO classification of prostate cancer: changes and novelties in the "Blue Book"

Hana Sedláčková, Ivan Trávníček, Adriena Bartoš Veselá, Tomáš Pitra, Milan Hora, Ondřej Fiala, Kristýna Pivovarčíková

Ces Urol 2023, 27(2):78-85 | DOI: 10.48095/cccu2023012  

Sedláčková H, Trávníček I, Bartoš Veselá A, Pitra T, Hora M, Fiala O, Pivovarčíková K. 5th edition of the 2022 WHO classification of prostate cancer: hanges and novelties in the "Blue Book". Recently (in the middle of 2022), a new WHO classification of urogenital tumors was published. This 5th edition of the so-called "Blue Book" comes with a comprehensive update of the terminology, epidemiology, pathogenesis, histopathology, diagnostic-molecular pathology and prognostic-predictive advances of urogenital tumors. This review article summarizes the main changes in the classification of prostate cancer.

Prognostic factors in metastatic prostate cancer

Alžběta Kantorová, Viktor Soukup, Otakar Čapoun

Ces Urol 2023, 27(2):86-94 | DOI: 10.48095/cccu2023013  

Kantorová A, Soukup V, Čapoun O. Prognostic factors in metastatic prostate cancer. Metastatic prostate cancer (mPC) is a heterogeneous group of diseases with a median survival of 42 months. The basic treatment of mPC is always a combined treatment with androgen deprivation therapy (ADT - androgen deprivation therapy) with new antiandrogens (ARTA - androgen receptor targeted agents) such as enzalutamide, apalutamide, darolutamide or with the new testosterone synthesis blocker abiraterone acetate (AA) or with chemotherapy (docetaxel, cabazitaxel). To determine prognosis, we use prognostic factors that correlate with survival independent of systemic therapy....

The results of percutaneous nephrostomy tube placement under ultrasound guidance

Simona Machynová, Michal Fedorko, Vítězslav Vít

Ces Urol 2023, 27(2):95-100 | DOI: 10.48095/cccu2023010  

Machynová S, Fedorko M, Vít V. The results of percutaneous nephrostomy tube placement under ultrasound guidance. Goal: We would like to present the experiences of our department with nephrostomy tube placement under ultrasound guidance, considering the low number of articles on this topic. Materials and Methods: In years 2018-2021, a total of 592 ultrasound-guided percutaneous nephrostomies were performed in 363 patients. The data was analyzed retrospectively. We evaluate the indications for the drainage of the upper urinary tract, the technical success rate and the number and type of complications. Results: The most common oncological indication was...

Long-term follow-up of living kidney donors - a single center experience

Michaela Matysková Kubišová, Jaroslav Pacovský, Pavel Navrátil jr., Roman Šafránek, Pavel Navrátil, Igor Guňka, Sylvie Dusilová Sulková

Ces Urol 2023, 27(2):101-108 | DOI: 10.48095/cccu2023014  

Matysková Kubišová M, Pacovský J, Navrátil P jr., Šafránek R, Navrátil P, Guňka I, Dusilová Sulková S. Long-term follow-up of living kidney donors - a single center expirience. Aim: The main condition for kidney transplants from a living donor is to ensure the donor's safety and exclude donation under duress. The aim of our work is to try to describe the risks arising from donation in the context of the current perspective, data from large sets of donors and control groups and describe our own results. Patients and methods: 56 pairs were enrolled in the retrospective study. The results of the donor were mainly monitored - serum creatinine values, the...

Early complications after radical cystectomy before implementation of the ERAS concept (Enhanced Recovery After Surgery)

Šárka Kudláčková, Igor Hartmann, Veronika Lounová, Jiří Neier

Ces Urol 2023, 27(2):109-115 | DOI: 10.48095/cccu2023017  

Kudláčková Š, Hartmann I, Lounová V, Neier J. Early complications after radical cystectomy before implementation of the ERAS concept (Enhanced Recovery After Surgery). Objective: Radical cystectomy (RACE) is an operation with numerous complications. The effort to reduce them led to the introduction of the ERAS (Enhanced Recovery After Surgery) concept used in colorectal surgery. Our goal is to demonstrate its benefits also in urological operations with interventions on the bowel. Material and methods: Before inclusion in the study, we evaluated a group of 86 patients who underwent RACE at our institution in the period 1/2017-12/2019. A Bricker ileostomy,...

Priapism durning testosterone replacement therapy of the central hypogonadism

Marek Broul, Jana Laštůvková, Vlasta Čejnová, Lucie Lišková, Filip Cihlář

Ces Urol 2023, 27(2):116-121 | DOI: 10.48095/cccu2023016  

Broul M, Laštůvková J, Čejnová V, Lišková L, Cihlář F. Priapism durning testosterone replacement therapy of the central hypogonadism. We present a case report of a patient who suffered from recurrent priapism after testosterone replacement therapy (TRT) for central hypogonadism. This complication of TRT is very rare and poorly described in the literature. The patient had to undergo cavernous body lavage but still experienced recurrent priapism. It was only after anti-androgen therapy was administered that the recurrence of priapism ceased.

Observations from CEM23 (Central European Meeting 2023)

Veronika Mlejnská, Adriena Bartoš Veselá, Jiří Kolář, Tra Mi Nguyenová, Hana Sedláčková, Milan Hora

Ces Urol 2023, 27(2):122-125